Malaria gets its second vax: Why it’s momentous

A malaria vaccine developed by Oxford University and Serum Institute of India (SII) has been recommended…

Serum HPV vaccine Cervavac hits mkt; 2-3 mn doses this yr

NEW DELHI : Homegrown pharma major Serum Institute of India has launched its indigenous Human Papillomavirus…

Serum Institute of India resumes manufacturing of COVID-19 vaccine Covishield

A health worker administers a dose of the Covishield vaccine against the coronavirus during a special…

SII seeks inclusion of COVID jab Covovax in CoWIN portal as asymmetric booster dose for adults

File image for representation. , Photo credit: Shiv Kumar Pushpakar Official sources said on Wednesday that…

Exclusive: “Tell China To Take Our Booster,” Adar Poonawalla Tells NDTV

Davos: Serum Institute of India is working to sell two of its lead vaccines for Covid…

DGCI approves market authorization for Covax as heterologous booster dose

Official sources told PTI on Monday that the Drug Controller General of India (DCGI) has granted…

HPV vaccine production delayed due to Covid focus, supply to Indian government to start in early 2023: SII | India News – Times of India

Pune: Serum Institute of India (siiHPV vaccine production had to be postponed for two years due…

SII plans diphtheria, tetanus, pertussis vaccine

Following the successful conduct of its COVID vaccine, Serum Institute of India is focusing on developing…

SII to supply 10 million doses of QHPV vaccine against cervical cancer by December end

With the risk of cervical cancer looming large on women in the age group of 14-55…

DCGI expert panel recommends SII’s qHPV vaccine for cervical cancer patients

The Subject Expert Committee of the Drugs Controller General of India (DCGI) on 15 June recommended…